StreetInsider.com News Articles

Form SCHEDULE 13G LifeMD, Inc. Filed by: FEDERATED HERMES, INC.

Wed, 08 Jul 2026 07:45:00 -0400

si-local-file:///var/storage/secattach/20260708/26744344.html

Form SCHEDULE 13G LifeMD, Inc. Filed by: FEDERATED HERMES, INC.

Wed, 08 Jul 2026 07:45:00 -0400

si-local-file:///var/storage/secattach/20260708/26744344.html

Form SCHEDULE 13G LifeMD, Inc. Filed by: FEDERATED HERMES, INC.

Wed, 08 Jul 2026 07:45:00 -0400

si-local-file:///var/storage/secattach/20260708/26744344.html

B.Riley revisits LifeMD Inc (LFMD) following Best Idea designation

Mon, 29 Jun 2026 07:24:43 -0400

B.Riley analyst Kyle Bauser reiterated a Buy rating and $10.00 price target on LifeMD Inc (NASDAQ: LFMD).

The analyst comments "We return to Buy-rated LFMD one month after naming it our best idea coming out of the B. Riley Securities 26th Annual Institutional Investor Conference. After topping $5 in mid-June, the stock has round-tripped to $4.13 at Friday's close, ~1.5% above where it traded exiting our conference. With the thesis intact and recent developments broadening the near-term catalyst path, we see the sell-off as a chance to buy a strengthened story at the same price. The standout new development is LFMD's

B.Riley revisits LifeMD Inc (LFMD) following Best Idea designation

Mon, 29 Jun 2026 07:24:43 -0400

B.Riley analyst Kyle Bauser reiterated a Buy rating and $10.00 price target on LifeMD Inc (NASDAQ: LFMD).

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Tue, 23 Jun 2026 08:00:00 -0400

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.

The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026.

About LifeMD, Inc.

LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Tue, 23 Jun 2026 08:00:00 -0400

The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026.

About LifeMD, Inc.

LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Tue, 23 Jun 2026 08:00:00 -0400

The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026.

About LifeMD, Inc.

LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Tue, 23 Jun 2026 08:00:00 -0400

The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026.

About LifeMD, Inc.

LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Tue, 23 Jun 2026 08:00:00 -0400

The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026.

About LifeMD, Inc.

LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Tue, 23 Jun 2026 08:00:00 -0400

The preferred dividend will be paid on July 15, 2026, to holders of record at the close of business on July 3, 2026.

About LifeMD, Inc.

LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access

Form 8-K LifeMD, Inc. For: Jun 22

Mon, 22 Jun 2026 08:26:00 -0400

si-local-file:///var/storage/secattach/20260622/26670355.html

Form 8-K LifeMD, Inc. For: Jun 22

Mon, 22 Jun 2026 08:26:00 -0400

si-local-file:///var/storage/secattach/20260622/26670355.html

Form 8-K LifeMD, Inc. For: Jun 22

Mon, 22 Jun 2026 08:26:00 -0400

si-local-file:///var/storage/secattach/20260622/26670355.html

LifeMD to launch self-pay testosterone program with Antares Pharma

Mon, 22 Jun 2026 08:01:18 -0400

LifeMD, Inc. (Nasdaq: LFMD) announced an exclusive co-marketing agreement with Antares Pharma, Inc., a wholly owned subsidiary of Halozyme, to support a direct-to-patient self-pay program for XYOSTED® (testosterone enanthate) injection, an FDA-approved once-weekly subcutaneous testosterone auto-injector.

The program is scheduled to launch in July 2026 and will initially be available in 37 states. Under the arrangement, LifeMD will serve as the exclusive telehealth co-marketing partner, with patient evaluations conducted through LifeMD's affiliated medical group and XYOSTED dispensed through LifeMD's pharmacy and shipped directly to patients' homes.

The self-pay program is priced at approximately $249 per month, covering both medication and clinical care

LifeMD to launch self-pay testosterone program with Antares Pharma

Mon, 22 Jun 2026 08:01:18 -0400

The self-pay program is priced at approximately $249 per month, covering both medication and clinical care

LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection

Mon, 22 Jun 2026 08:00:00 -0400

Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, launching in July 2026 in 37 states